Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22363 | 328 | 34.5 | 65% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EGF DEXTRAN | Author keyword | 6 | 80% | 1% | 4 |
2 | ANTIBODY BINDING PARAMETERS | Author keyword | 3 | 60% | 1% | 3 |
3 | BIOMED RADIAT SCI | Address | 2 | 11% | 6% | 19 |
4 | DIMETHYLLYSINE | Author keyword | 2 | 67% | 1% | 2 |
5 | PROSTHETIC RADIOIODINATION | Author keyword | 2 | 67% | 1% | 2 |
6 | RADIOCHEM UNIT | Address | 2 | 67% | 1% | 2 |
7 | RESIDUALIZING LABEL | Author keyword | 2 | 50% | 1% | 3 |
8 | IN VIVO DEIODINATION | Author keyword | 1 | 100% | 1% | 2 |
9 | INDIRECT RADIOBROMINATION | Author keyword | 1 | 100% | 1% | 2 |
10 | N SUCCINIMIDYL 4 IODOBENZOATE | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EGF DEXTRAN | 6 | 80% | 1% | 4 | Search EGF+DEXTRAN | Search EGF+DEXTRAN |
2 | ANTIBODY BINDING PARAMETERS | 3 | 60% | 1% | 3 | Search ANTIBODY+BINDING+PARAMETERS | Search ANTIBODY+BINDING+PARAMETERS |
3 | DIMETHYLLYSINE | 2 | 67% | 1% | 2 | Search DIMETHYLLYSINE | Search DIMETHYLLYSINE |
4 | PROSTHETIC RADIOIODINATION | 2 | 67% | 1% | 2 | Search PROSTHETIC+RADIOIODINATION | Search PROSTHETIC+RADIOIODINATION |
5 | RESIDUALIZING LABEL | 2 | 50% | 1% | 3 | Search RESIDUALIZING+LABEL | Search RESIDUALIZING+LABEL |
6 | IN VIVO DEIODINATION | 1 | 100% | 1% | 2 | Search IN+VIVO+DEIODINATION | Search IN+VIVO+DEIODINATION |
7 | INDIRECT RADIOBROMINATION | 1 | 100% | 1% | 2 | Search INDIRECT+RADIOBROMINATION | Search INDIRECT+RADIOBROMINATION |
8 | N SUCCINIMIDYL 4 IODOBENZOATE | 1 | 100% | 1% | 2 | Search N+SUCCINIMIDYL+4+IODOBENZOATE | Search N+SUCCINIMIDYL+4+IODOBENZOATE |
9 | REDUCTIVE METHYLATION | 1 | 16% | 2% | 6 | Search REDUCTIVE+METHYLATION | Search REDUCTIVE+METHYLATION |
10 | RADIOBROMINATION | 1 | 40% | 1% | 2 | Search RADIOBROMINATION | Search RADIOBROMINATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENHANCES CELLULAR RETENTION | 15 | 82% | 3% | 9 |
2 | IODOBENZOATE | 13 | 80% | 2% | 8 |
3 | TYRAMINE CELLOBIOSE | 13 | 80% | 2% | 8 |
4 | ACYLATION AGENT | 12 | 75% | 3% | 9 |
5 | RADIOHALOGENATION | 10 | 39% | 6% | 21 |
6 | N SUCCINIMIDYL 5 IODO 3 PYRIDINECARBOXYLATE | 8 | 56% | 3% | 10 |
7 | 5 IODO 3 PYRIDINECARBOXYLATE | 6 | 80% | 1% | 4 |
8 | PEPTIDIC VECTOR | 6 | 80% | 1% | 4 |
9 | RADIOIODINATION | 6 | 21% | 7% | 24 |
10 | RESIDUALIZING IODINE RADIOLABEL | 5 | 63% | 2% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Reductive alkylation of lysine residues to alter crystallization properties of proteins | 1997 | 92 | 6 | 50% |
Quality assurance in radiopharmaceutical production | 2008 | 0 | 3 | 100% |
Targeted radiotherapy of brain tumours | 2004 | 21 | 26 | 46% |
Approaches to improve cellular retention of radiohalogen labels delivered by internalising tumour-targeting proteins and peptides | 2003 | 17 | 110 | 44% |
Review of methods to assign the nuclear magnetic resonance peaks of reductively methylated proteins | 2014 | 1 | 28 | 29% |
Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression | 2006 | 8 | 105 | 25% |
THE DESIGN AND APPLICATION OF RESIDUALIZING LABELS FOR STUDIES OF PROTEIN CATABOLISM | 1993 | 43 | 35 | 23% |
Radioimmunotherapy for high-grade glioma | 2013 | 2 | 82 | 21% |
RESIDUALIZING GLYCOCONJUGATES - BIOLOGICALLY INERT TRACERS FOR STUDIES ON PROTEIN ENDOCYTOSIS AND CATABOLISM | 1994 | 2 | 14 | 57% |
RADIOHALOGENATION OF PROTEINS - AN OVERVIEW OF RADIONUCLIDES, LABELING METHODS, AND REAGENTS FOR CONJUGATE LABELING | 1992 | 152 | 179 | 12% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMED RADIAT SCI | 2 | 11% | 5.8% | 19 |
2 | RADIOCHEM UNIT | 2 | 67% | 0.6% | 2 |
3 | LIM 50 | 1 | 50% | 0.3% | 1 |
4 | PAEDIAT NEUROONCOL S | 1 | 50% | 0.3% | 1 |
5 | UNIT EXPT UROL | 1 | 50% | 0.3% | 1 |
6 | IMAMREZA HOSP | 0 | 33% | 0.3% | 1 |
7 | INVEST SAFETY ASSESSMENT | 0 | 33% | 0.3% | 1 |
8 | RADIOFARM | 0 | 13% | 0.9% | 3 |
9 | MED NUCL MED SAKYO KU | 0 | 13% | 0.3% | 1 |
10 | UNIV HOSP CASE MED MED | 0 | 11% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000205626 | AT 211//TARGETED ALPHA THERAPY//BI 213 |
2 | 0.0000204856 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY |
3 | 0.0000173571 | RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN |
4 | 0.0000139475 | AUGER ELECTRONS//AUGER ELECTRON EMITTER//CELLULAR DOSIMETRY |
5 | 0.0000139124 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
6 | 0.0000121692 | FLUOROESTRADIOL//F 18 FES PET//FES PET |
7 | 0.0000121246 | AFFIBODY MOLECULE//AFFIBODY MOLECULES//AFFIBODY |
8 | 0.0000082940 | EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS |
9 | 0.0000082614 | IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG |
10 | 0.0000072151 | SOMATOSTATIN RECEPTOR SCINTIGRAPHY//PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//OCTREOTATE |